Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
, 111 (1), 30-50; quiz 51

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus

Affiliations
Practice Guideline

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus

Nicholas J Shaheen et al. Am J Gastroenterol.

Erratum in

Abstract

Barrett's esophagus (BE) is among the most common conditions encountered by the gastroenterologist. In this document, the American College of Gastroenterology updates its guidance for the best practices in caring for these patients. These guidelines continue to endorse screening of high-risk patients for BE; however, routine screening is limited to men with reflux symptoms and multiple other risk factors. Acknowledging recent data on the low risk of malignant progression in patients with nondysplastic BE, endoscopic surveillance intervals are attenuated in this population; patients with nondysplastic BE should undergo endoscopic surveillance no more frequently than every 3-5 years. Neither routine use of biomarker panels nor advanced endoscopic imaging techniques (beyond high-definition endoscopy) is recommended at this time. Endoscopic ablative therapy is recommended for patients with BE and high-grade dysplasia, as well as T1a esophageal adenocarcinoma. Based on recent level 1 evidence, endoscopic ablative therapy is also recommended for patients with BE and low-grade dysplasia, although endoscopic surveillance continues to be an acceptable alternative. Given the relatively common recurrence of BE after ablation, we suggest postablation endoscopic surveillance intervals. Although many of the recommendations provided are based on weak evidence or expert opinion, this document provides a pragmatic framework for the care of the patient with BE.

Comment in

Similar articles

See all similar articles

Cited by 222 articles

See all "Cited by" articles

References

    1. Am J Gastroenterol. 2007 Jun;102(6):1154-61 - PubMed
    1. Clin Gastroenterol Hepatol. 2004 Oct;2(10):868-79 - PubMed
    1. Am J Gastroenterol. 2008 Apr;103(4):850-5 - PubMed
    1. N Engl J Med. 2011 Oct 13;365(15):1375-83 - PubMed
    1. Gastroenterology. 2013 Jan;144(1):62-73.e6 - PubMed

Publication types

Feedback